Inhaled hydrogen sulfide: A rapidly reversible inhibitor of cardiac and metabolic function in the mouse

Anesthesiology

Volumn 108, Issue 4, 2008, Pages 659-668

  Volpato, Gian Paolo ^a   Searles, Robert ^a   Yu, Binglan ^a   Scherrer Crosbie, Marielle ^b   Bloch, Kenneth D ^a   Ichinose, Fumito ^a   Zapol, Warren M ^a,b  

^a Anesthesia Center for Critical Care Research

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; HYDROGEN SULFIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; BREATHING RATE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ENVIRONMENTAL TEMPERATURE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; MALE; MEAN ARTERIAL PRESSURE; METABOLIC INHIBITION; MOUSE; NONHUMAN; OXYGEN BLOOD LEVEL; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; ROOM TEMPERATURE; SINUS NODE; TELEMETRY;

EID: 41149146946     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318167af0d     Document Type: Article

References (28)

1. Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA: A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 1984; 13:25-97
2. Holstege CP, Isom GE, Kirk MA: Cyanide and hydrogen sulfide, Goldfrank's Toxicologic Emergencies, 8th edition. Edited by Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS. New York, McGraw-Hill Medical Publishing Division, 2006, pp 1712-24
3. Phillips SD: Hydrogen sulfide, Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient, 5th edition. Edited by Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW. Philadelphia, Elsevier-Mosby, 2005, pp 1029-33
4. Reiffenstein RJ, Hulbert WC, Roth SH: Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 1992; 32:109-34
5. Dorman DC, Moulin FJ, McManus BE, Mahle KC, Arden James R, Struve MF: Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: Correlation with tissue sulfide concentrations in the rat brain, liver, lung and nasal epithelium. Toxicol Sci 2002; 65:18-25
6. 2S induces a suspended animation-like state in mice. Science 2005; 308:518
7. Blackstone E, Roth MB: Suspended animation-like state protects mice from lethal hypoxia. Shock 2007; 27:370-2
8. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vançon AC, Huang PL, Lee RT, Zapol WM, Picard MH: Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001; 104:1286-91
9. Wyatt HL, Meerbaum S, Heng MK, Gueret P, Corday E: Cross-sectional echocardiography: III. Analysis of mathematic models for quantifying volume of symmetric and asymmetric left ventricles. Am Heart J 1980; 100:821-8
10. G-L-arginine methylester on the threshold for isoflurane anesthesia. ANESTHESIOLOGY 1995; 83:101-8
11. ATP channel opener. EMBO J 2001; 20:6008-16
12. Geng B, Du J, Tang C: Application of sensitive sulphur electrode assay to measure and analyze cystathionine γ-lyase/hydrogen sulfide pathway of cardiovascular tissues, cells and plasma in rats [in Chinese]. Beijing Da Xue Xue Bao 2005; 37:545-8
13. Chen L, Ingrid S, Ding Y, Liu Y, Qi J, Tang C, Du J: Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J 2007; 120:389-93
14. Searcy DG, Peterson MA: Hydrogen sulfide consumption measured at low steady state concentrations using a sulfidostat. Anal Biochem 2004; 324:269-75
15. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313:362-8
16. Hosoki R, Matsuki N, Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237:527-31
17. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283:H474-80
18. ATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 2005; 68:1757-64
19. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR: Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 2005; 288:R243-52
20. Ali MY, Ping CY, Mok Y-YP, Ling L, Whiteman M, Moore PK: Regulation of vascular nitric oxide in vitro and in vivo: A new role for endogenous hydrogen sulfide? Br J Pharmacol 2006; 149:625-34
21. Struve MF, Brisbois JN, James RA, Marshall MW, Dorman DC: Neurotoxological effects associated with short-term exposure of Sprague-Dawley rats to hydrogen sulfide. Neurotoxicology 2001; 22:375-85
22. Nicholoson RA, Roth SH, Jian Zheng AZ, Brookes J, Skrajny B, Bennington R: Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain. J Toxicol Environ Health Part A 1998; 54:491-507
23. Greer JJ, Reifenstein RJ, Almeida AF, Carter E: Sulfide-induced perturbations of the neuronal mechanisms controlling breathing in rats. J Appl Physiol 1995; 78:433-40
24. Carey HV, Andrews MT, Martin SL: Mammalian hibernation: Cellular and molecular responses to depressed metabolism and low temperature. Physiol Rev 2003; 83:1153-81
25. Mortola JP, Frappell PB: Ventilatory responses to changes in temperature in mammals and other vertebrates. Annu Rev Physiol 2000; 62:847-74
26. Mortola JP: Influence of temperature on metabolism and breathing during mammalian ontogenesis. Respir Physiol Neurobiol 2005; 149:155-64
27. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK: Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 2005; 6:1-17
28. Szabó C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6:917-35